Monoclonal antibody: Campath (alemtuzumab) -1H it is a monoclonal antibody ( immunoglobulin structure) a large protein that binds to CD 52 , a surface receptor on mature lymphocytes. The CD 52 bearing lymphocytes will be targeted for destruction This makes it a drug useful to treat CLL ,(chronic lymphocytic leukemia ) Was withdraw from the markets in 2012 to prepare for a launch of a more expensive drug to treat MS
Answered 11/30/2014
3.5k views
Anti-leukemia drug: This is hard to explain in 400 characters, but here is a website with a good explanation of the drug, it's uses, how it works, and other useful information. http://chemocare.com/chemotherapy/drug-info/alemtuzumab.aspx
Answered 12/10/2014
3.5k views
A doctor has provided 1 answer
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question